Safety of Secretrol® in the Short-term Management of Patients Undergoing Endoscopic Mucosal Resection (EMR)
Clinical trial NCT02210494 · UNKNOWN
Trial details
- NCT number
- NCT02210494
- Sponsor
- Effexus Pharmaceutical
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2015-08-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.